# Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness

> **NCT07339943** · NA · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 7 (estimated)

## Conditions studied

- Prostate Cancer (Adenocarcinoma)
- Low and Intermediate Risk Prostate Cancer

## Interventions

- **PROCEDURE:** 6 month, prospective, interventional single-arm safety and effectiveness study
- **DEVICE:** The TRANBERG|CLS Thermal therapy

## Key facts

- **NCT ID:** NCT07339943
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-30
- **Primary completion:** 2026-05-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 7 (ESTIMATED)
- **Last updated:** 2026-01-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07339943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07339943, "Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07339943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*